In contrast, VEGFCc156s treatment significantly reduced these parameters compared with animals that had been treated with angiotensin II alone, suggesting that VEGFCc156s treatment alleviated angiotensin II-induced kidney damage. The gene discussed is AGT; the disease is Nephropathy.